Nrf2 Inhibits Epithelial-mesenchymal Transition by Suppressing Snail Expression During Pulmonary Fibrosis
Authors
Affiliations
Epithelial-mesenchymal transition (EMT) is a phenotype conversion that plays a critical role in the development of pulmonary fibrosis (PF). It is known that snail could regulate the progression of EMT. Nuclear factor erythroid 2 related factor 2 (Nrf2), a key regulator of antioxidant defense system, protects cells against oxidative stress. However, it is not known whether Nrf2 regulates snail thereby modulating the development of PF. Here, bleomycin (BLM) was intratracheally injected into both Nrf2-knockout (Nrf2) and wild-type mice to compare the development of PF. Rat type II alveolar epithelial cells (RLE-6TN) were treated with a specific Nrf2 activator sulforaphane, or transfected with Nrf2 and snail siRNAs to determine their effects on transforming growth factor β1 (TGF-β1)-induced EMT. We found that BLM-induced EMT and lung fibrosis were more severe in Nrf2 mice compared to wild-type mice. In vitro, sulforaphane treatment attenuated TGF-β1-induced EMT, accompanied by the down-regulation of snail. Inversely, silencing Nrf2 by siRNA enhanced TGF-β1-induced EMT along with increased expression of snail. Interestingly, when snail was silenced by siRNA, sulforaphane treatment was unable to reduce the progression of EMT in RLE-6TN cells. These findings suggest that Nrf2 attenuates EMT and fibrosis process by regulating the expression of snail in PF.
Proteomic Approach to Study the Effect of Colonization in Idiopathic Pulmonary Fibrosis.
Carmona-Pirez J, Salsoso R, Charpentier E, Olmedo C, Medrano F, Roman L J Fungi (Basel). 2025; 11(2).
PMID: 39997396 PMC: 11857022. DOI: 10.3390/jof11020102.
Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A Cell Commun Signal. 2024; 22(1):542.
PMID: 39538298 PMC: 11558984. DOI: 10.1186/s12964-024-01925-y.
Nrf-2 as a novel target in radiation induced lung injury.
Chen Y, Wang M, Zuo C, Mao M, Peng X, Cai J Heliyon. 2024; 10(8):e29492.
PMID: 38665580 PMC: 11043957. DOI: 10.1016/j.heliyon.2024.e29492.
Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases.
Liu X, Wang X, Chang J, Zhang H, Cao P Front Pharmacol. 2023; 14:1190817.
PMID: 37305540 PMC: 10250599. DOI: 10.3389/fphar.2023.1190817.
Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity.
Matouk A, Awad E, El-Tahawy N, El-Sheikh A, Anter A Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111238 PMC: 10145727. DOI: 10.3390/ph16040481.